These results highlight the importance of the CXCR3/CXCL10/11 chemokine axis in CD8+ T cell-mediated SCC tumour regression and suggest that CXCR3 blockade prevents SCC regression by impairing the infiltration of CD8+ T cells into tumours. The gene discussed is CD8A; the disease is neoplasm.